EAACI Congress 2024
BackDermatology 3
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
12:00
Corticosteroids in Atopic Dermatitis - A Love Hate Relationship?
12:00
Dermatological Dichotomy: A Case of Coexisting Atopic Dermatitis and Mycosis Fungoides
12:00
Effects of topical JAK inhibitor on skin inflammation and itching in FADS mouse
12:00
Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study
12:00
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
12:00
Fixed drug eruption caused by lansoprazole
12:00
Genetic aspects among Brazilian patients with Atopic Dermatitis: are Filaggrin variants relevant in the pathogenesis of the disease?
12:00
Infant atopic dermatitis and maternal anxiety and depression: a mixed methods case-control study
12:00
Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab
12:00
Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective
